CAPR Competitors & Alternatives
Compare Capricor Therapeutics Inc with similar stocks in the same industry
Biotechnology
CAPR
Main Stock$22.22
Tradestie Score
51
Market Cap
$357.51M
Revenue Growth
-0.1%
Analyst Upside
+141.2%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$23.24
|
$1.35B | - | 54 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$39.72
|
$1.32B | - | 61 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.94
|
$1.29B | 119.6 | 57 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$33.02
|
$1.29B | - | 62 | Compare |
|
ARDX
Ardelyx, Inc.
|
$5.38
|
$1.29B | - | 48 | Compare |
|
ZYME
Zymeworks Inc.
|
$26.72
|
$1.28B | - | 55 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$5.67
|
$1.27B | - | 54 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$44.93
|
$1.26B | - | 58 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$5.19
|
$1.22B | - | 58 | Compare |
More CAPR Analysis
Data updated: Jul 08, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry